JPMorgan Chase & Co’s Bicycle Therapeutics BCYC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.1K | Buy |
7,637
+593
| +8% | +$4.12K | ﹤0.01% | 5078 |
|
|
2025
Q1 | $59.8K | Sell |
7,044
-663
| -9% | -$5.63K | ﹤0.01% | 4964 |
|
|
2024
Q4 | $108K | Sell |
7,707
-717
| -9% | -$10K | ﹤0.01% | 4751 |
|
|
2024
Q3 | $191K | Buy |
8,424
+1,782
| +27% | +$40.3K | ﹤0.01% | 4474 |
|
|
2024
Q2 | $134K | Sell |
6,642
-8,946
| -57% | -$181K | ﹤0.01% | 4467 |
|
|
2024
Q1 | $388K | Buy |
15,588
+5,482
| +54% | +$137K | ﹤0.01% | 4104 |
|
|
2023
Q4 | $183K | Sell |
10,106
-58,393
| -85% | -$1.06M | ﹤0.01% | 4487 |
|
|
2023
Q3 | $1.38M | Sell |
68,499
-27,652
| -29% | -$556K | ﹤0.01% | 3233 |
|
|
2023
Q2 | $2.45M | Buy |
96,151
+9,013
| +10% | +$230K | ﹤0.01% | 2918 |
|
|
2023
Q1 | $1.85M | Buy |
87,138
+3,932
| +5% | +$83.6K | ﹤0.01% | 3083 |
|
|
2022
Q4 | $2.46M | Sell |
83,206
-42,483
| -34% | -$1.26M | ﹤0.01% | 2829 |
|
|
2022
Q3 | $2.92M | Buy |
125,689
+42,231
| +51% | +$982K | ﹤0.01% | 2676 |
|
|
2022
Q2 | $1.4M | Buy |
83,458
+73,555
| +743% | +$1.23M | ﹤0.01% | 3255 |
|
|
2022
Q1 | $434K | Buy |
9,903
+7,075
| +250% | +$310K | ﹤0.01% | 4079 |
|
|
2021
Q4 | $172K | Buy |
2,828
+1,463
| +107% | +$89K | ﹤0.01% | 4608 |
|
|
2021
Q3 | $57K | Sell |
1,365
-691
| -34% | -$28.9K | ﹤0.01% | 4913 |
|
|
2021
Q2 | $63K | Buy |
2,056
+754
| +58% | +$23.1K | ﹤0.01% | 4888 |
|
|
2021
Q1 | $39K | Buy |
+1,302
| New | +$39K | ﹤0.01% | 4843 |
|